This year’s Asthma & COPD 2015 will be held at the Holiday Inn Regent’s Park Hotel between April 13 and 14, 2015 in London, United Kingdom, and will include prominent scientists, clinicians and industry leaders who will gather to discuss the latest findings on respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). To give a preview of what the event has in store for its attendees, SMi, the global event-production company organizing the conference, has released the top 10 reasons why attending the Asthma & COPD 2015 conference is a must:
- “Expertise” — The conference will feature a global audience of scientific leaders, academia and respiratory professionals, who are going to discuss today’s emerging treatments and diagnostics.
- An agenda that includes 20 presentations delivered by representatives of esteemed institutions, such as Amgen, MedImmune, Asthma UK and Imperial College London, offering an “Unrivaled Speaker Line-Up.”
- Other industry experts from leading companies and institutions such as Janssen, GlaxoSmithKline, AstraZeneca and the University of Glasglow, who will present a series of “Case Studies” on diagnosing and treating asthma and COPD.
- “14 Hours of Content,” during which pediatric therapies, personalized treatment, viruses related to asthma and COPD, NHS challenges and “smart” inhaled devices will be discussed.
- “Join the Debate” – Opportunities for presenter-audience interaction, with a panel discussing the challenges and choices in stratified asthma therapeutics. The discussion will be led by Robert Nivel, a senior lecturer in Respiratory Medicine at the Manchester University, who also heads one of the only four facilities in the UK working on severe asthma and a national database program.
- Janssen has been invited to share the findings of its “Adept Study,” which will be featured during the “Airways disease endotyping for personalized therapeutics in asthma & COPD” presentation.
- Attendees will be able to hear from the executive director for research and policy of Asthma UK, Samantha Walker about the organization’s “Partnership Focus” during the keynote “Changing role of patient charities in research — what can we offer?” The lecture will be focused on the importance of multi-partner collaborations, benefits of working with charities, and their approach to creating research collaborations with industry.
- An “Interactive Workshop” on surpassing obstacles related to the registration of new respiratory medications. The workshop will provide insights on how functional respiratory imaging can offer new, detailed information and clear performance measures, which can determine the success of a drug’s development process.
- Enabling Technology” will be discussed in two exclusive keynotes, focusing on the impact of both personal and digital economies, such as personal health technologies, smart devices or functional lung imaging, in the field of respiratory health.
- The opportunity to engage in “Networking” through the debates, morning coffee breaks, networking lunches or afternoon tea sessions.
Both asthma and COPD represent two serious lung-related health complications that have devastating impacts on people, public health, and economies. Both diseases are responsible for rising healthcare costs, lost productivity, and long-term disability. By bringing together the pulmonary community, presenting the latest developments, and identifying unmet treatment needs, Asthma & COPD 2015 hopes to accelerate research and drug development in both Asthma and COPD, improving patient outcomes.